LABRADOR GRANADOS, María
LABRADOR GRANADOS, María
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma
2026-01-01 Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto
CRISPR activation screen identifies MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma
2023-01-01 María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Elisabetta Mereu, Tina Paradzik, Cecilia Bandini, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri.
CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma.
2025-01-01 Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva.
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines
2023-01-01 Mereu, Elisabetta; Abbo, Damiano; Paradzik, Tina; Cumerlato, Michela; Bandini, Cecilia; Labrador, Maria; Maccagno, Monica; Ronchetti, Domenica; Manicardi, Veronica; Neri, Antonino; Piva, Roberto
Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma
2022-01-01 María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva
Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma
2024-01-01 Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva.
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition
2024-01-01 Piva, Roberto; Gharari, Nariman; Labrador, Maria; Mader, Sylvie
LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies
2022-01-01 Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
2023-01-01 Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma
2026-01-01 Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma | 2026 | Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto | |
| CRISPR activation screen identifies MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma | 2023 | María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Elisabetta Mereu, Tina Paradzik, Cecilia Bandini, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri. | |
| CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma. | 2025 | Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva. | |
| Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines | 2023 | Mereu, Elisabetta; Abbo, Damiano; Paradzik, Tina; Cumerlato, Michela; Bandini, Cecilia; Labrador, Maria; Maccagno, Monica; Ronchetti, Domenica; Manicardi, Veronica; Neri, Antonino; Piva, Roberto | |
| Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma | 2022 | María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva | |
| Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma | 2024 | Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva. | |
| IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition | 2024 | Piva, Roberto; Gharari, Nariman; Labrador, Maria; Mader, Sylvie | |
| LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies | 2022 | Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva | |
| Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma | 2023 | Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto | |
| MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma | 2026 | Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto |